Genetic alterations in BMPR1A, BMPR1B, or BMPR2 were found in around 6, 7, or 5% of patients with breast cancer, respectively, with the major form of genetic alternation being an upregulation of mRNA encoding BMP receptors (data not shown). This evidence concerns the gene BMPR2 and breast cancer.